Vernia P - Search Results

1

Topical butyrate for acute radiation proctitis: randomised, crossover trial.

Vernia P, Fracasso PL, Casale V, Villotti G, Marcheggiano A, Stigliano V, Pinnaro P, Bagnardi V, Caprilli R. Vernia P, et al. Lancet. 2000 Oct 7;356(9237):1232-5. doi: 10.1016/s0140-6736(00)02787-2. Lancet. 2000. PMID: 11072942 Clinical Trial.

2

Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study.

Vernia P, Monteleone G, Grandinetti G, Villotti G, Di Giulio E, Frieri G, Marcheggiano A, Pallone F, Caprilli R, Torsoli A. Vernia P, et al. Dig Dis Sci. 2000 May;45(5):976-81. doi: 10.1023/a:1005537411244. Dig Dis Sci. 2000. PMID: 10795763 Clinical Trial.

3

Short-chain fatty acid topical treatment in distal ulcerative colitis.

Vernia P, Marcheggiano A, Caprilli R, Frieri G, Corrao G, Valpiani D, Di Paolo MC, Paoluzi P, Torsoli A. Vernia P, et al. Aliment Pharmacol Ther. 1995 Jun;9(3):309-13. doi: 10.1111/j.1365-2036.1995.tb00386.x. Aliment Pharmacol Ther. 1995. PMID: 7654893 Clinical Trial.

4

Topical treatment of refractory distal ulcerative colitis with 5-ASA and sodium butyrate.

Vernia P, Cittadini M, Caprilli R, Torsoli A. Vernia P, et al. Dig Dis Sci. 1995 Feb;40(2):305-7. doi: 10.1007/BF02065414. Dig Dis Sci. 1995. PMID: 7851194

5

Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial.

Vernia P, Annese V, Bresci G, d'Albasio G, D'Incà R, Giaccari S, Ingrosso M, Mansi C, Riegler G, Valpiani D, Caprilli R; Gruppo Italiano per lo Studio del Colon and del Retto. Vernia P, et al. Eur J Clin Invest. 2003 Mar;33(3):244-8. doi: 10.1046/j.1365-2362.2003.01130.x. Eur J Clin Invest. 2003. PMID: 12641543 Clinical Trial.

6

Multiple organ dysfunction in ulcerative colitis.

Caprilli R, Latella G, Vernia P, Frieri G. Caprilli R, et al. Among authors: vernia p. Am J Gastroenterol. 2000 May;95(5):1258-62. doi: 10.1111/j.1572-0241.2000.02019.x. Am J Gastroenterol. 2000. PMID: 10811337

7

Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis.

Viscido A, Habib FI, Kohn A, Papi C, Marcheggiano A, Pimpo MT, Vernia P, Cadau G, Caprilli R. Viscido A, et al. Among authors: vernia p. Aliment Pharmacol Ther. 2003 May 15;17(10):1263-71. doi: 10.1046/j.1365-2036.2003.01535.x. Aliment Pharmacol Ther. 2003. PMID: 12755839 Free article.

8

Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.

D'Ovidio V, Vernia P, Gentile G, Capobianchi A, Marcheggiano A, Viscido A, Martino P, Caprilli R. D'Ovidio V, et al. Among authors: vernia p. J Clin Virol. 2008 Oct;43(2):180-3. doi: 10.1016/j.jcv.2008.06.002. Epub 2008 Jul 9. J Clin Virol. 2008. PMID: 18614396

9

Sorbitol malabsorption and nonspecific abdominal symptoms in type II diabetes.

Vernia P, Frandina C, Bilotta T, Ricciardi MR, Villotti G, Fallucca F. Vernia P, et al. Metabolism. 1995 Jun;44(6):796-9. doi: 10.1016/0026-0495(95)90195-7. Metabolism. 1995. PMID: 7783666

10

Pathogenetic mechanisms of inflammatory bowel disease.

Caprilli R, Peña A, Dianzani F, Pallone F, Vernia P. Caprilli R, et al. Among authors: vernia p. Ital J Gastroenterol. 1995 Jul-Aug;27(6):313-26. Ital J Gastroenterol. 1995. PMID: 8562998 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page